Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Kathleen Jentsch-Ulrich"'
Autor:
Andreas Schmidt, Christiane Bernhardt, Anette Fries, Kathleen Jentsch-Ulrich, Andreas Josting, Stephan Kreher, Marcel Reiser, H. Tilman Steinmetz, Hans Tesch, Bernhard Kaufmann, Uta Rager, Carl C. Crodel, Francesca Palandri, Florian H. Heidel
Publikováno v:
Blood. 140:9698-9699
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::057c83250ea76422c7696605f542b8dc
https://doi.org/10.1182/blood-2022-157980
https://doi.org/10.1182/blood-2022-157980
Autor:
William Krüger, Bernhard Heinrich, Martin Wilhelm, Vanja Zeremski, Norbert Grobe, Bastian von Tresckow, Peter Borchmann, Michael Fuchs, Jesko Momotow, Tobias Gaska, Burkhard Schmidt, Ina Bühnen, Andreas Hüttmann, Doris Kraemer, Paul J Bröckelmann, Gerhard Heil, Karolin Trautmann-Grill, Andreas Engert, Helmut Forstbauer, Guido Kobbe, Kathleen Jentsch-Ulrich
Publikováno v:
Blood. 138:4533-4533
Background: Immune-checkpoint inhibition with antibodies targeting programmed death protein 1 (PD1) was well tolerable and highly effective in pivotal phase II and III trials in relapsed or refractory (r/r) classical Hodgkin lymphoma (cHL). We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46f4fa998cd0b51bd010947552baaada
https://doi.org/10.1182/blood-2021-153200
https://doi.org/10.1182/blood-2021-153200
Autor:
Florian H. Heidel, Andreas Hochhaus, Carl C Crodel, M. Reiser, Regine Wunschel, Kathleen Jentsch-Ulrich, Siegfried W. Prenninger, Lutz Jacobasch, Philipp Kiewe, Jörg Lipke, Jens Kisro
Publikováno v:
Blood. 134:1672-1672
Treatment recommendations for cytoreductive treatment of patients with polycythemia vera (PV) are well established. However, the clinical use and limitation of phlebotomies remain a matter of current debate (Barbui et al, Leukemia, 32; Heidel et al,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ca0f67b476a46049e3505923babd3bc
https://doi.org/10.1182/blood-2019-122681
https://doi.org/10.1182/blood-2019-122681
Autor:
Peter Malfertheiner, Gerhard Treiber, Kathleen Jentsch-Ulrich, Jie Chen, Christoph Röcken, Matthias P. Ebert
Publikováno v:
Digestive Diseases. 21:357-362
Background: Alpha-fetoprotein (AFP)-producing gastric adenocarcinoma has an extremely poor prognosis. Few cases have been reported in Germany until now. Here we report on a patient with an AFP-producing gastric cancer and a subsequent analysis of AFP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24fe995bfb8102e5baa31b55c7697714
https://doi.org/10.1159/000075360
https://doi.org/10.1159/000075360
Autor:
Karl-Anton Kreuzer, Othman Al-Sawaf, Kathleen Jentsch-Ulrich, Anna-Maria Fink, Ali Aldaoud, Michael Kneba, Steffen Doerfel, Francesc Bosch, Barbara Eichhorst, Kirsten Fischer, Holger Hebart, Sebastian Boettcher, Michael Hallek, Hartmut Döhner, Arnon P. Kater, Clemens M. Wendtner, Jasmin Bahlo, Thomas Noesslinger, Stephan Stilgenbauer, Robrecht Sandra, Paolo Ghia
Publikováno v:
Blood. 128:229-229
Introduction: The combined use of genetic markers and minimal residual disease (MRD) assessment identifies CLL patients (pts) with a poor outcome after front line chemoimmunotherapy. The CLLM1 study was initiated to evaluate lenalidomide as a mainten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9e5c2ab883b4c2b92a093891862b1d0
https://doi.org/10.1182/blood.v128.22.229.229
https://doi.org/10.1182/blood.v128.22.229.229
Autor:
Holger Hebart, Karl-Anton Kreuzer, Clemens-Martin Wendtner, Michael Pfreundschuh, Georg Maschmeyer, Hartmut Döhner, Arnon P. Kater, Paolo Ghia, Michael Hallek, Kathleen Jentsch-Ulrich, Anna-Maria Fink, Aline Zey, Stephan Stilgenbauer, Thomas Noesslinger, Anne Westermann, Sebastian Boettcher, Kirsten Fischer, Barbara Eichhorst, Steffen Dörfel, Jasmin Bahlo, Francesc Bosch
Publikováno v:
Blood. 124:4699-4699
Introduction: CLL patients (pts) with persistence of minimal residual disease (MRD) after frontline chemoimmunotherapy or an unfavourable genetic profile have a high risk of early relapse and a short survival (Fink et al., Leukemia 2013). Therefore,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7aed0f72973c18a96f15d06616875297
https://doi.org/10.1182/blood.v124.21.4699.4699
https://doi.org/10.1182/blood.v124.21.4699.4699
Autor:
Peter Lohse, Oliver Müller, Marc A. Reymond, Peter Rauh, Stephanie Lamer, Lüder M. Fels, Volker Keim, Ralf Steinert, Ferenc Sipos, Helga-Paula Török, Matthias P.A. Ebert, Hans Lippert, Malte Buchholz, Christoph Röcken, Kathleen Jentsch-Ulrich, Orsolya Galamb, Steffen Rickes, Thomas M. Gress, Frank Eder, Jörn Meuer, Jie Chen, Jürgen Glas, Gerhard Treiber, Catherine Lofton-Day, Michael Fleischhacker, Ralf Lesche, Hermann Lage, Béla Molnár, Peter Malfertheiner, Christian Folwaczny, Walter Halangk, Abdelkarim S. Allal, Matthias P. Ebert, Zsolt Tulassay, Thomas Buschmann
Publikováno v:
Digestive Diseases. 21:369-370
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::de04fc3f39b8a87c20e319f00f0676e3
https://doi.org/10.1159/000076558
https://doi.org/10.1159/000076558
Autor:
Zsolt Tulassay, Peter Malfertheiner, Volker Keim, Lüder M. Fels, Ralf Steinert, Ferenc Sipos, Orsolya Galamb, Peter Rauh, Thomas Buschmann, Steffen Rickes, Matthias P.A. Ebert, Catherine Lofton-Day, Kathleen Jentsch-Ulrich, Malte Buchholz, Marc A. Reymond, Abdelkarim S. Allal, Christoph Röcken, Ralf Lesche, Hermann Lage, Michael Fleischhacker, Matthias P. Ebert, Stephanie Lamer, Peter Lohse, Oliver Müller, Helga-Paula Török, Hans Lippert, Jörn Meuer, Jie Chen, Thomas M. Gress, Frank Eder, Christian Folwaczny, Gerhard Treiber, Walter Halangk, Jürgen Glas, Béla Molnár
Publikováno v:
Digestive Diseases. 21:368-368
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::befb768cc1763e03de7de4e254f105ac
https://doi.org/10.1159/000076557
https://doi.org/10.1159/000076557
Autor:
Ebert, M.
Even though the knowledge of the pathogenesis of cancers and inflammatory diseases of the gastrointestinal tract has greatly increased in recent years, their clinical management remains a challenge. Detailing the clinical potential of new technologie
